PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.400
https://www.valueinhealthjournal.com/article/S1098-3015(11)01962-0/fulltext
Title :
PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01962-0&doi=10.1016/j.jval.2011.08.400
First page :
A304
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
370